Comparing the phenotypes of non-APL AML and APL, in addition to HLA-DR and CD34, we found significant differences in the expression of markers CD13, MPO, CD15, CD64, CD2 and CD7. This evidence concerns the gene MPO and acute myeloid leukemia.